ArticleEuropean child & adolescent psychiatry2026
Cognitive disengagement syndrome across attention deficit/hyperactivity disorder, autism spectrum disorder, and internalizing disorders: towards a transdiagnostic construct.
Article in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on: Cognitive disengagement syndrome across attention deficit/hyperactivity disorder, autism spectrum disorder, and internalizing disorders: Towards a transdiagnostic construct.European child & adolescent psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive Disengagement Syndrome (CDS) refers to symptoms of fogginess, daydreaming, blank staring, and slowed behaviour. Growing evidence suggests that CDS reflects a transdiagnostic construct. This study aimed to examine (1) associations between age, sex, and CDS severity; (2) differences in CDS across Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), and internalizing disorders; and (3) associations between CDS and quality of life, as assessed by the KIDSCREEN-27. CDS was assessed in 958 clinically referred children and adolescents (mean age = 10.7 ± 2.8 years; 36.3% female) with a primary diagnosis of ADHD (n = 353), ASD (n = 494), or internalizing disorders (n = 111). Four Child Behaviour Checklist (CBCL) items (13, 17, 80, 102) were used to operationalize CDS. Analyses included ANOVAs, MANOVAs, and multiple regression analyses in the full sample and a subsample without comorbidities. CDS levels didn't differ by sex, whereas adolescents (12-17 years) showed higher CDS levels than children (6-11 years). Across diagnostic groups, ASD (M = 2.6, SD = 1.8) and internalizing disorders (M = 2.6, SD = 1.9) displayed higher CDS scores than ADHD (M = 1.8, SD = 1.6; p < .001). These findings remained significant in the subsamples without comorbidities (p < .001). Multiple regression analyses indicated that higher CDS scores were significantly associated with lower quality of life (B = -2.20, p < .001), independent of diagnostic group, sex, and age, without significant interaction between CDS and diagnosis. Correlational analyses indicated stronger associations between CDS with autistic (r = .25-.36; p < .05) and affective CBCL symptom dimensions (r = .19-.36; p < .05) dimensions than with ADHD symptoms. CDS appears to represent a clinically relevant transdiagnostic construct. Its strong expression in ASD suggests that it captures disengagement mechanisms beyond current nosological frameworks.
Indexed as
Identifiers
42171690What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.